Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
Under Federal anti-kickback regulations, giving referring physicians software has long counted as a valuable gift that could induce improper referrals. Now the government is recognizing that this well intentioned regulation may be harming efforts to increase interoperability of electronic health records (EHRs)
Health care employment rose by in March to 14,516,600 people, making it one of the few bright spots in the Bureau of Labor Statistics monthly jobs report
The technology could allow brain imaging of patients such as infants, children or adults with conditions that make holding still without restraints and anesthesia difficult
Merge Healthcare Inc. has commenced a cash tender offer for any and all of its $252 million outstanding aggregate principal amount of 11.75% Senior Secured Notes due 2015
Starting on January 1, 2014, all mammography providers in Hawaii must inform women with dense breast tissue about their breast density status at the time they deliver mammography results.
CMS’ Proposed Decision Memo for Positron Emission Tomography (FDG) for Solid Tumors crept under the radar last month, but strong reactions from industry associations are finally surfacing.
The Wall Street Journal took a break from writing about all that is wrong with the economics of health care delivery to highlight something that is right — the efforts of radiologists to reduce duplicate scans through image sharing and make it easier for patients to get second opinions.
The efforts of organizations like the Medical Imaging Technology Alliance (MITA) to end the medical device tax that went into effect this year drew the sharp rebuke of the New York Times' editorial board.